Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All WW International, Inc. filings on SEC EDGAR ↗
WW International announced its intention to use up to $10 million in cash to prepay a portion of its outstanding term loan at a discount. The company is conducting a voluntary solicitation of offers from its lenders to facilitate this debt reduction. Additionally, the company reaffirmed its full-year 2026 financial guidance.
WW International President and CEO Stephen J. Bye Buys $138K of Stock
Stephen J. Bye, President and CEO, bought 12,500 shares of WW International, Inc. at $11.01 a share, worth $138K in total on Nov 10, 2026. Shares held after the trade: 12,500.
WW International Director Lisa A. Gavales Buys $55.1K of Stock
Lisa A. Gavales, Director, bought 5,000 shares of WW International, Inc. at $11.03 a share, worth $55.1K in total on Nov 10, 2026. Shares held after the trade: 5,000.
WW International reported a net income of $15.1 million for the quarter ended September 30, 2026, a significant recovery from a $57.5 million loss in the prior year period. However, for the nine months ended September 30, 2026, the company recorded a net loss of $22.8 million as subscription revenues declined from $170.9 million to $152.0 million year-over-year.
WW International reported Q3 2026 revenue of $152.9 million, driven by 48% year-over-year growth in Clinical Subscription Revenue. The company achieved a net income of $15.1 million and narrowed its full-year 2026 revenue guidance to a range of $625 million to $630 million.
Term
Q3 2026
“Since joining Weight Watchers on October 1, I made it my priority to listen to our members, coaches, clinicians, registered dietitians, and colleagues. Through these conversations, two core truths emerged: weight loss is personal, and the support people need changes along the way.”
Stephen Bye, President and Chief Executive Officer
“We remained focused on strengthening our two higher-value product offerings and proactively calibrating our spend across our portfolio. That approach helped drive sustained progress in these offerings with four quarters of quarter-over-quarter growth in Core+ subscribers, and the largest year-over-year Clinical Subscription Revenue growth percentage in any quarter of 2026 to date.”
WW International, Inc. announced that Stephen J. Bye will officially begin his role as President and Chief Executive Officer on October 1, 2026. Upon his commencement, the Interim Office of the Chief Executive will be dissolved, and Felicia DellaFortuna and Jonathan Volkmann will return to their respective roles as CFO and COO.